Title : Caffeic acid phenethyl ester (CAPE) exhibits significant potential as an antidiabetic and liver-protective agent in streptozotocin-induced diabetic rats.

Pub. Date : 2009 Oct

PMID : 19717012






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 CAPE treatments enhanced the expressions of glucokinase (3.4-14.9-folds), and pyruvate kinase (3.2-12.8-folds) mRNAs in diabetic rats. caffeic acid phenethyl ester glucokinase Rattus norvegicus
2 CAPE exhibits a significant potential as an antidiabetic agent by suppressing hepatic glucose output via inducing mRNA expression of glucokinase and pyruvate kinase, whilst inhibiting phoshoenolpyruvate carboxykinase in diabetes. caffeic acid phenethyl ester glucokinase Rattus norvegicus